rare revolution

Views & Analysis

The next generation of rare disease advocates need a little support in getting their voices heard as part of the Rare Youth Project.

News

City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.